title: Who is at high risk of recurrent venous thrombosis and do they really benefit from continuation of anticoagulation? Clinicians wield a double-edged sword that might cut nothing at all.
authors.affiliation: Division of Hemostasis and Thrombosis, Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; K.G. Jebsen - Thrombosis Research and Expertise Center, The Arctic University of Norway, Tromsø, Norway.
authors.forename: Y I G V
authors.initials: YI
authors.lastname: Tichelaar
authors.affiliation: Department of Clinical Epidemiology, Leiden University Medical Center, C7-P, PO Box 9600, 2300 RC Leiden, The Netherlands.
authors.forename: W M
authors.initials: WM
authors.lastname: Lijfering
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D012008:Recurrence; D012307:Risk Factors; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology
chemical_list: D000925:Anticoagulants